New Horizon Health 1H21: On Track to a Strong Year
Post 1H21 results, we continue to like the company and believe the current weakness presents opportunities to accumulate the stock.
166 Views
HSI Index Rebalance Preview: Potential Inclusions in September
There could be 8 additions to the HSI at the September review to take the index members up to 66. Turnover will be less than 5% and there are a lot...
466 Views
HSCI Index Rebalance and Stock Connect: Potential Changes in June and September
A look at the potential changes to the HSCI at the June & September reviews and stocks that could be included in/excluded from Stock Connect. These...
514 Views
New Horizon Health (6606.HK) - Still Has a Long Way to Go
The article analyzed the major concerns in China’s market of early screening (difficulty in BD, pricing, payment systems, etc.), which would...
282 Views
ECM Weekly (21 February 2021) - Tencent Lock-Up Expiry, SciClone Pharma, Joinn Lab, Bairong, Betta
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
570 Views